RENAISSANCE TECHNOLOGIES LLC

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,601,056

+$4,807,754 QoQ

Shares Held

357,200

+197.4% QoQ

Ownership

0.666%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#40

of 126 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. AVTX ranks #70 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,601,056	357,200	+197.4%	Shares	Sole	2026-08-13
2026-03-31	$1,793,302	120,114	+556.4%	Shares	Sole	2026-05-14
2025-12-31	$332,328	18,300	-81.5%	Shares	Sole	2026-02-12
2025-09-30	$1,254,477	98,700	-71.0%	Shares	Sole	2025-11-13
2022-06-30	$170,015	340,032	-7.4%	Shares	Sole	2022-08-12
2022-03-31	$266,214	367,193	+819.1%	Shares	Sole	2022-05-13
2021-12-31	$67,918	39,952	+42.8%	Shares	Sole	2022-02-11
2021-09-30	$60,998	27,981	—	Shares	Sole	2021-11-12
2021-03-31 CERC	—	284,793	+164.9%	Shares	Sole	2021-05-13
2020-12-31 CERC	—	107,493	-45.8%	Shares	Sole	2021-02-10
2020-09-30 CERC	—	198,331	-59.0%	Shares	Sole	2020-11-13
2020-06-30 CERC	—	484,081	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.